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SHORT REPORT
Regulator of calcineurin-2 is a centriolar protein with a role in cilia
length control
Nicola L. Stevenson1,*, Dylan J. M. Bergen1,*, Amadeus Xu1, Emily Wyatt1, Freya Henry1, Janine McCaughey1,
Laura Vuolo1, Chrissy L. Hammond2 and David J. Stephens1,‡
ABSTRACT
Almost every cell in the human body extends a primary cilium.
Defective cilia function leads to a set of disorders known as
ciliopathies, which are characterised by debilitating developmental
defects that affect many tissues. Here, we report a new role for
regulator of calcineurin 2 (RCAN2) in primary cilia function. It localises
to centrioles and the basal body and is required to maintain normal
cilia length. RCAN2 was identified as the most strongly upregulated
gene from a comparative RNAseq analysis of cells in which
expression of the Golgi matrix protein giantin had been abolished
by gene editing. In contrast to previous work where we showed that
depletion of giantin by RNAi results in defects in ciliogenesis and in
cilia length control, giantin knockout cells generate normal cilia after
serum withdrawal. Furthermore, giantin knockout zebrafish show
increased expression of RCAN2. Importantly, suppression of RCAN2
expression in giantin knockout cells results in the same defects in the
control of cilia length that are seen upon RNAi of giantin itself.
Together, these data defineRCAN2 as a regulator of cilia function that
can compensate for the loss of giantin function.
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INTRODUCTION
Ciliogenesis, the emergence of a microtubule axoneme from the
mother centriole, is fundamental for the ability of non-cycling cells to
sense and respond to their environment (Lechtreck, 2015). Defects in
the formation and/or function of the cilium lead to a cohort of human
diseases known as ciliopathies (Braun and Hildebrandt, 2016), which
affect multiple tissues leading to problems with respiratory, kidney
and heart function, as well as vision, hearing and fertility. Cilia
defects are also linked to obesity and diabetes. Movement of cargo
and signalling complexes into and out of cilia requires intraflagellar
transport (IFT), the process by which microtubule motors drive
motility along the axoneme. The ability of cilia to act as confined
signalling hubs directing key developmental and homeostatic
pathways, such as those linked to sonic hedgehog (Shh) signalling
(He et al., 2016) or mechanosensing, requires the trafficking of
receptors and associated signalling molecules into cilia (He et al.,
2016; Sung and Leroux, 2013). This includes ligand-gated receptors,
G-protein-coupled receptors, Ca2+ channels and transcription factors.
Considerable work supports a major role for Ca2+ in ciliary function
(Delling et al., 2013). Resting cilium [Ca2+] is substantially higher
than resting cytoplasmic [Ca2+], and ciliary [Ca2+] is important for
cells to respond to Shh through activation of Gli transcription factors
(Delling et al., 2013).
We have shown previously using RNAi that the coiled-coil Golgi
protein giantin is required for ciliogenesis in vitro (Asante et al., 2013).
This was linked to the accumulation of the dynein-2 motor complex
around the ciliary base.Dynein-2 is themajormotor driving retrograde
IFT along the axoneme and is, among other functions, required for the
transduction of the Shh signal (He et al., 2016). Consistent with our
findings using RNAi in cultured cells, morpholino knockdown of
giantin in zebrafish resulted in fewer but longer cilia in the neural tube
(Bergen et al., 2017). In contrast, recent characterisation of giantin
knockout (KO) zebrafish shows that, although they breed and develop
similarly towild-type fish, giantin KO fish showa significant decrease
in body length (more notable in young adults) and have defects in
extracellularmatrix, cartilage andbone formation, but have onlyminor
cilia defects (Bergen et al., 2017).
We recently generated a KO cell line that no longer expresses
giantin (Stevenson et al., 2017). Here, we show that in contrast to
depletion of giantin, complete knockout of the gene does not
prevent cells from generating cilia on serum withdrawal. We
hypothesised that compensatory mechanisms might enable KO cells
to produce normal cilia, whereas acute suppression of expression
using RNAi did not allow such compensation. Such mechanisms
would also explain the relatively mild manifestation of ciliary
defects in giantin mutant zebrafish compared with the effects of
in vivo morpholino knockdown. RNAseq showed that RCAN2
(regulator of calcineurin-2; also called calcipressin-2 and ZAKI-4)
is the most strongly upregulated gene in these giantin KO cells.
Here, we show that RCAN2 localises to centrioles and its depletion
affects ciliogenesis. Furthermore, removal of RCAN2 in giantin KO
cells recapitulates the giantin RNAi ciliary length phenotype.
RESULTS AND DISCUSSION
Giantin KO cells show no gross defects in ciliogenesis
Using RNAi, we have shown previously that a reduction in the
expression of giantin is associated with a ciliogenesis defect in cells
(Asante et al., 2013). Giantin-depleted cells produce fewer cilia and
those that remain are longer, suggesting a defect in length control. In
contrast, analysis of giantin KORPE-1 cells (Stevenson et al., 2017)
shows no gross defects in ciliogenesis at the level of light
microscopy (Fig. 1A, quantified in B) or any significant change
in cilia length (Fig. 1A, quantified fully in later experiments). Using
serial section transmission electron microscopy (TEM), we detected
no obvious abnormalities in the structure of the basal body,
appendages or ciliary pocket (Fig. 1C, enlarged in Cii).
Furthermore, Golgi structure appears normal (see Stevenson et al.,Received 19 October 2017; Accepted 4 April 2018
1Cell Biology Laboratories, School of Biochemistry, University of Bristol, Biomedical
Sciences Building, University Walk, Bristol, UK, BS8 1TD. 2School of Physiology
and Pharmacology, University of Bristol, Biomedical Sciences Building, University
Walk, Bristol, UK, BS8 1TD.
*These authors contributed equally to this work
‡Author for correspondence (david.stephens@bristol.ac.uk)
N.L.S., 0000-0001-8967-7277; D.J.M.B., 0000-0001-7808-6121; C.L.H., 0000-
0002-4935-6724; D.J.S., 0000-0001-5297-3240
1













2017). This phenotypic discrepancy between knockdown and KO
cells is consistent with our observations in zebrafish (Bergen et al.,
2017) and led us to hypothesise that altered expression of another
gene or genes compensates for the loss of giantin. A caveat to these
experiments is that wewere only able to derive one knockout line for
giantin in RPE1 cells.
Fig. 1. Giantin knockout RPE1 cells have no obvious defects in ciliogenesis. (A) Representative images of RPE1 WT and giantin KO cells fixed after 24 h
of serum starvation and labelled for Arl13B (red) and acetylated tubulin (green); nuclei are stained with DAPI (blue). Scale bars: 10 μm and 5 μm (inset).
(B) Quantification of the experiment represented in A (n=3). The mean percentage of cells producing cilia does not change upon KO of giantin. Error bars
represent s.d., Mann-Whitney U-test. (C) TEM images of (i) serial and (ii) single plane 70 nm sections through representative WT and giantin KO cilia at two
different magnifications.
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RNAseq of triplicate RNA samples from these and control cells
followed by pairwise statistical comparison identified 1025 genes
whose expression level is decreased >4-fold. These data are
described in Stevenson et al. (2017) and the raw data are available
via the ArrayExpress database (www.ebi.ac.uk/arrayexpress) under
accession number E-MTAB-5618. The most highly upregulated
gene, and therefore the most likely to underpin any compensation
for loss of giantin, is RCAN2. RCAN2 is a negative regulator of
calcineurin and modulates Ca2+-dependent signalling. Calcineurin
is required for transcriptional signalling; RCAN2 acts as a negative
regulator of nuclear factor of activated T-cells (NFAT) activation
and therefore of NFAT-dependent transcription. RNAseq showed
that in giantin KO cells, RCAN2 is >256× upregulated compared
with levels in the parental cell line (Stevenson et al., 2017),
implicating RCAN2 in cell adaptation to the lack of giantin.
To determine whether RCAN2 upregulation is a conserved
response to loss of giantin, we examined expression of RCAN2 in
two giantin KO zebrafish lines (Bergen et al., 2017). Using cDNA
derived from young adult dissected jaw and skull bone and cartilage
elements, qPCR expression analyses showed that zebrafish rcan2 is
3.9- and 2.5-fold up-regulated in giantin X3078 andQ2948Xmutant
lines, respectively, when normalised to β-actin (actb1) as a control
(Fig. 2A). Expression levels of hypoxanthine-guanine
phosphoribosyl transferase 1 (hprt1) and glyceraldehyde-3-
phosphate dehydrogenase (gapdh) were not significantly changed.
This shows that upregulation of RCAN2 following loss of giantin is
conserved and is therefore consistent with the hypothesis that the
limited phenotypes seen in both giantin KO models are due to
compensation. This also reduces concerns arising from the analysis
of only one giantin knockout RPE1 cell line. We postulated that if
this dramatic increase in expression is responsible for the limited
phenotypes of giantin knockouts, then RCAN2 should have a key
role in ciliogenesis.
The localisation of RCAN2 has not been reported.
Immunofluorescence of RCAN2 in RPE-1 cells showed that it
localised to centrioles (Fig. 2B) and occasionally showed enhanced
localisation to the mother centriole (25±11% of cells, n=3
independent experiments) from which the primary cilium extends
(shown by acetylated tubulin labelling in Fig. 2C). This was
confirmed by labelling with the distal appendage protein CEP170
(Fig. 2D) which can be used as a marker of the mother centriole
(Huang et al., 2017). In those cases where only one centriole is
evident from RCAN2 labelling (7±3% of cells; n=3 independent
experiments), we always see the axoneme extending from a
centriole and CEP170 associated with that centriole.
To determine whether RCAN2 was compensating for giantin
depletion with respect to cilium length, we depleted RCAN2 using
two individual siRNA duplexes (Fig. 3) as well as a pool of 4
duplexes (Fig. S1). This experiment validated the specificity of the
antibody used since centriolar labelling was lost following RNAi
suppression of RCAN2 expression (Fig. 3A). The efficacy of
suppression was measured as a function of the intensity of RCAN2
labelling at the centrioles (Fig. 3B). Unfortunately, the antibody was
not suitable for immunoblotting. Depletion of RCAN2 did not affect
the proportion of cells that could generate cilia following serum
withdrawal (Fig. 3C). Quantification of these data showed that in
wild-type (WT) RPE-1 cells, suppression of RCAN2 resulted in
shorter cilia (Fig. 3D). In contrast, depletion of RCAN2 in giantin
KO cells resulted in longer cilia, even when compared with control
cilia lengths. Our hypothesis was that RCAN2 could be suppressing
the phenotypes seen following acute loss of giantin in RNAi
experiments, namely an increase in cilia length. Consistent with
this, we see that reducing the levels of RCAN2 in giantin KO cells
recapitulates the longer cilia phenotypes seen upon giantin
knockdown in WT cells (Asante et al., 2013). Depletion of
RCAN2 has no effect on the integrity of the Golgi or on targeting of
the glycosyltransferase galactosyltransferase T (GalT) (Fig. S1B
versus Fig. S1A). The efficacy of depletion of RCAN2 using a pool
of 4 siRNA duplexes is also shown (Fig. S1D). It was not possible to
study the effects of RCAN2 overexpression in these experiments as
transfection with myc-RCAN2 blocked ciliogenesis in >80% of
transfected cells. Attempts to titrate expression levels were
unsuccessful.
Our data strongly suggest that upregulation of RCAN2
ameliorates defects in cilia length control. The phenotypes we
observe following acute and partial depletion of giantin in
mammalian cells (Asante et al., 2013) and zebrafish embryos
(Bergen et al., 2017) are not seen following permanent loss of
function of giantin. The fact that RCAN2 depletion leads to shorter
cilia in WT cells and longer cilia in giantin KO cells probably
reflects a general loss of length control rather than a linear
relationship whereby increasing RCAN2 levels leads to reducing
cilium lengths. In WT cells depleted of RCAN2, cilia are unable to
maintain their length and so become shorter, whereas in giantin KO
cells, the loss of length regulation means the effects of giantin loss
become dominant and cilia become longer.
It is interesting that our data implicate cilium length control by
compensatory pathways in vitro in proliferating cells. The
importance of cilia to cell growth in culture is poorly understood
and we cannot therefore predict whether defective ciliogenesis alone
would provide sufficient adaptive pressure for upregulation of
RCAN2. It is possible, however, that loss of giantin results in a
pro-ciliary phenotype that is compensated for by upregulation of
RCAN2. In support of this, we found that overexpression of myc-
RCAN2 results in far fewer cells (<20%) that produce cilia (Fig. 4A,
n=100 cells) and there were also a few incidences (∼10% of myc-
RCAN2-expressing cells) where we could detect Arl13b-positive
structures devoid of acetylated-tubulin labelling (Fig. 4B). These are
similar in appearance to the ‘decapitated’ cilia that have been
described by others to drive cilia resorption and cell cycle
progression (Phua et al., 2017). In addition, RCAN2 may be
acting as a regulator of gene transcription through NFAT signalling
to correct other deficiencies in the KO cells. For example, we have
shown previously that the glycosyltransferase content of the Golgi is
altered in giantin KO cells, suggesting that glycosylation defects
arising from loss of giantin function might have been corrected to
generate bioequivalent glycans (Stevenson et al., 2017).
Many studies have shown that RCAN2 regulates calcineurin-
dependent activation of NFAT signalling, and subsequently,
NFAT-dependent transcriptional programmes. To confirm that
upregulation of RCAN2 in giantin KO cells is of functional
importance, we examined localisation of NFAT1 in WT and giantin
KO cells using immunofluorescence (Fig. 4C). As shown in
Fig. 4D, the ratio of nuclear versus cytoplasmic levels of NFAT1
was higher in giantin KO cells compared with that in WT cells. This
nuclear localisation was further enhanced in response to serum
starvation. The distribution of NFAT1 in cells depleted of giantin by
shRNA was similar to that in WT cells, supporting our argument
that acute depletion of giantin does not induce adaptation within
these timescales, hence the longer cilia. The higher level of RCAN2
expression seen in the giantin KO cells could thus result in greater
activation of the calcineurin-NFAT signalling pathways. Although
RCAN2 is commonly considered to be a negative regulator of
calcineurin (Cao et al., 2002; Loh et al., 1996), other studies have
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found that it can positively promote NFAT signalling (Sanna et al.,
2006), as appears to be the case here. Alternatively, enhanced
RCAN2 expression could result from attempts to suppress
upregulated calcineurin-based signalling. Activation of NFAT
signalling has been described to occur downstream of α6β4
integrin activation in metastatic cancer cells (Jauliac et al., 2002)
and RCAN1 can modulate cancer cell migration (Espinosa et al.,
2009). Of note, both giantin KO cells and giantin KO fish have
substantial defects in extracellular matrix-related functions (Bergen
et al., 2017; Stevenson et al., 2017). Thus, we speculate that changes
in matrix glycoproteins could be the trigger for compensatory
changes in gene expression in giantin KO models.
Rodent knockouts for giantin (rat: Katayama et al., 2011 and
mouse: Lan et al., 2016) exhibit defects in extracellular matrix
secretion and assembly, cartilage and bone formation, and have
syndromic cleft palate. RCAN2 KO mice are viable but show
selective defects in osteoblast function (Bassett et al., 2012), in
impaired intramembranous ossification, and in cortical bone
formation. Indeed, loss of RCAN2 function is associated with
reduced bone mass, whereas giantin mutant zebrafish (with
increased RCAN2) show enhanced bone formation in the
intervertebral discs (Stevenson et al., 2017). Evidence also exists
that inhibition of calcineurin using cyclosporin is linked to cilia
function, shown by the presence of abnormal basal bodies in
proximal convoluted tubule cells from patients receiving
Cyclosporin A (Kirwan, 1982). Ciliary dysfunction is frequently
linked to skeletal defects. Indeed, the ‘skeletal ciliopathies’ are
grouped according to phenotypic descriptions of skeletal defects
(Huber and Cormier-Daire, 2012). These diseases include Jeune
syndrome in which subunits of the dynein-2 motor are mutated.
Fig. 2. RCAN2 localises to centrioles. (A)
qPCR of two giantin zebrafish mutant lines
(Q2948X and X3078) compared with wild-
type sibling controls shows that rcan2 is
strongly upregulated relative to the
housekeeping gene actb1. In contrast, hprt1
and gapdh are not upregulated. (B)
Endogenous RCAN2 (red) localises to
centrioles labelled with γ-tubulin (green) in
hTERT-RPE1 cells. Scale bar: 10 μm. (C)
RCAN2 is frequently (25±11%, n=3
independent experiments) found
concentrated at the mother centriole (from
which the cilium extends) as shown by
acetylated tubulin labelling of the ciliary
axoneme (arrowhead). Where only one
puncta of RCAN2 labelling is found (asterisk;
7±3% of cells, n=3 independent
experiments), a ciliary axoneme is always
found extending from this centriole. (D) The
distal appendage protein CEP170 is
associated with the brighter of the two
RCAN2-positive centrioles (arrowhead) as
well as with single centrioles positive for
CEP170 (asterisk). Boxes are 5×5 µm; >50
cells were analysed in each of the
independent experiments in B-D.
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Fig. 3. RCAN2 compensates for loss of function of giantin in cilia length control. (A) Depletion of RCAN2 using two different siRNA duplexes (1 and 2)
is effective as judged by reduced centriolar labelling compared with cells transfected with control siRNA (GL2). Two examples are shown in each case.
Scale bars: 1 µm. (B) Quantification of experiment shown in A. Depletion of RCAN2 results in shorter cilia in WT RPE-1 cells but longer cilia in giantin KO
cells compared with GL2-transfected controls. (C) Depletion of RCAN2 does not affect the ability of cells to produce cilia. (D) Quantification of cilia length in
RCAN2-depleted WT and giantin KO RPE-1 cells. Depletion of RCAN2 in wild-type RPE-1 cells results in a decrease in cilium length. In contrast, depletion
of RCAN2 in giantin KORPE-1 cells increases cilia length, even when compared withWT cells. Statistical significance was tested using one-way, non-parametric
ANOVA (Kruskal-Wallis test) with Dunn’s multiple comparisons test. N≥35 cilia were measured in each case from 3 independent biological replicates; ns,
not significant.
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Intriguingly, our work has led from the biology of giantin to the
dynein-2 intraflagellar transport motor (Asante et al., 2013) and on
to the identification of RCAN2 as a key regulator of ciliary function.
These and other findings implicate RCAN2 and calcineurin in
transcriptional regulation via cilia. This provides a potential point of
integration at the nexus of Ca2+ and ciliary signalling. In support of
Fig. 4. Giantin KO cells show higher levels of NFAT1 activation. (A) Expression of myc-RCAN2 (red in merge) prevents cilia formation as shown by acetylated
tubulin or Arl13b (both pseudocoloured green in merge; images were obtained from cells triple labelled with Alexa Fluor 488, 568 and 647). 80% of myc-RCAN2-
expressing cells failed to extend a cilium (n=100). (B) In 5% of these myc-RCAN2-expressing cells, we observed ‘decapitated’ cilia, positive for Arl13b but not
for acetylated tubulin. (C) Representative images showing WT and giantin KO and knockdown (KD) cells grown in serum or serum deprived for 24 h and
then immunolabelled for NFAT1. Scale bars: 10 μm. (D) Quantification of the ratio of nuclear to cytoplasmic NFAT1 staining intensity in experiments
represented in A [n=3, bars represent median and interquartile range, P-values calculated using non-parametric ANOVA (Kruskal-Wallis test with Dunn’s
multiple comparisons test)].
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this, tax-6, the C. elegans orthologue of calcineurin, regulates the
trafficking of the key ciliary protein polycystin-2 (PKD2) (Hu et al.,
2006). PKD2 is a Ca2+-permeable cation channel that is mutated in
15% of cases of autosomal dominant polycystic kidney disease. Of
note here, the partner of PKD2, PKD1 (mutated in the other 85% of
ADPKD cases) is understood in osteoblasts to be a mechanoreceptor
transducing signals from the cilia to induce osteoblastic gene
transcription by potentiating Ca2+-dependent calcineurin-NFAT
signalling (Dalagiorgou et al., 2013). Its role in canonical NFAT
signalling suggests a mechanism by which it could regulate coupling
of ciliary Ca2+ to cellular functions through transcriptional control.
Our findings also have significant potential for understanding the
mechanisms of cilia-based Ca2+-dependent signal transduction,
including modulation of Shh signalling through Gli (Delling et al.,
2013). One possibility is that the concentration of RCAN2 at the base
of the cilium acts to quench Ca2+-dependent calcineurin signalling,
restricting it to the cilium itself. Understanding the role of RCAN2 in
ciliary signalling will therefore have significant implications for
diverse areas of fundamental importance to our understanding of cell
function, as well as clinical relevance in bone formation, renal
function, developmental signalling and mechanosensing.
MATERIALS AND METHODS
All reagents were purchased from Sigma-Aldrich unless stated otherwise.
Cell culture
Human telomerase-immortalised retinal pigment epithelial cells (hTERT-
RPE-1, ATCC) were grown in DMEM-F12 supplemented with 10% FCS
(Life Technologies, Paisley, UK). Cell lines were not authenticated after
purchase other than confirming absence of mycoplasma contamination.
Transfections were performed using Lipofectamine 2000 according to the
manufacturer’s instructions (Invitrogen, Carlsbad, CA). Myc-DDK-tagged-
human RCAN2 (NCBI accession number NM_005822.2) was purchased
from Generon (Maidenhead, UK).
Knockout models
Giantin KO RPE-1 cells have been described previously (Stevenson et al.,
2017) and Giantin KO zebrafish are described in Bergen et al. (2017). London
AB, Tupfel long fin (TL) and AB/TL zebrafish were used and maintained
according to standard conditions (Westerfield, 2000), kept in 3.5 litre tanks in
groups of ≤15 adult fish, and staged accordingly (Kimmel et al., 1995).
Ethical approval was obtained from the University of Bristol Ethical Review
Committee using the Home Office Project License number 30/2863.
RNAi
RCAN2 was depleted in RPE-1 cells using RNA interference. siRNA
duplexes directed against RCAN2 were made by Dharmacon [MQ-020054-
01-0002 siGENOMEHuman RCAN2 (10231), Dharmacon, GEHealthcare].
Transfections were carried out using either a control or RCAN2 siRNA. Four
pooled siRNAs were used to deplete RCAN2, with the following target
sequences, RCAN2 siRNA #1 (GGAUAGAGCUUCAUGAAAC), RCAN2
siRNA #2 (CGUAUAAACUUCAGCAAUC), RCAN2 siRNA #3 (CCAC-
GCCAGUCCUCAACUA) and RCAN2 siRNA #4 (GCUCUACUUUGC-
ACAGGUU). GL2 control siRNA (CGUACGCGGAAUACUUCGAUU)
was used as a negative control. All siRNA reagents were prepared in 2 M
CaCl2 and incubated for 5 min at room temperature before an equal volume of
2× BES buffered solution (BBS) was added to the solution and allowed to
equilibrate for a further 30 min at room temperature. Final siRNA
concentrations used were 5 μM. Confluent RPE-1 cells were grown on
round 22 mm glass coverslips in Costar 6-well plates and incubated at 37°C,
3%CO2 for 24 h before replacing the growthmedium.Cellswere grown for an
additional 24 h at 37°C, 5% CO2 then serum starved for ciliogenesis assays.
Antibodies, labelling and microscopy
Antibodies used: mouse monoclonal anti-giantin (full-length,
Abcam, ab37266; 1:1000), rabbit polyclonal anti-giantin (N-terminus,
Covance, PRB-114C; 1:1000), rabbit anti-RCAN2 (GTX31373, Insight
Biotechnology, London UK; 1:500), anti-Arl13b (17711-1-AP, Proteintech,
Manchester, UK; 1:1000), sheep anti-myc was a kind gift fromHarryMellor
(University of Bristol) 1:1000, Fan et al., 2010 (PMID: 20233848),
sheep anti-GRASP65 was a kind gift from Jon Lane (University of Bristol)
Cheng et al., (2010) PMID: 21368855, anti-GalT (CB002, CellMab,
Gothenberg, Sweden; 1:500), anti-NFAT1 (GTX127932, GeneTex, Insight
Biotechnology, London, UK; 1:500).
For antibody labelling, cells were grown on autoclaved coverslips
(Menzel #1.5, Fisher Scientific, Loughborough, UK), rinsed with PBS
and fixed in methanol for 4 min at −20°C. Cells were then blocked in 3%
BSA-PBS for 30 min and incubated with primary then secondary antibody
for 1 h each, washing in between. Nuclei were stained with DAPI [4,6-
diamidino-2-phenylindole (Life Technologies, Paisley, UK, D1306)] for
3 min and coverslips mounted in Mowiol (MSD, Hertfordshire, UK) or
Prolong Diamond antifade (Thermo Fisher, Paisley, UK). Fixed cells were
imaged using an Olympus IX70 microscope with 60×1.42 NA oil-
immersion lens, Exfo 120 metal halide illumination with excitation,
dichroic and emission filters (Semrock, Rochester, NY), and a Photometrics
Coolsnap HQ2 CCD, controlled by Volocity 5.4.1 (Perkin Elmer, Seer
Green, UK). Chromatic shifts in images were registration corrected using
TetraSpek fluorescent beads (Thermo Fisher). Images were acquired as
0.2 µm z-stacks. Electron microscopy methods are descried fully in
Stevenson et al. (2017).
Reverse transcriptase PCR and quantitative real-time PCR
Young adult fish [60 and 63 days post fertilisation for Q2948X (F4) and
X3078 (F3) lines respectively, 3 individuals from each genotype group]
were lethally anaesthetised (<0.15% Tricaine) and their frontal skull and
ventral jaw bone and cartilage elements were carefully dissected using a
standard dissecting microscope. From these separate samples, total RNA
was isolated using RNeasy mini kit (cat# 74104, Qiagen) and reverse
transcriptase reaction was performed by using Superscript III (cat#
18080093, Thermo Fisher Scientific) according to the manufacturers’
protocols. Quantitative Real-Time PCR (qPCR) reaction [with the following
primers: rcan2 (ENSDART00000143379.2) F, 5′-CCAGGTGCAGAAC-
CCAGTAT-3′ and R, 5′-CCTCAGACCCTGGTTGTGTT-3′; hprt1 F,
5′-ATGGACCGAACTGAACGTCT-3′ and R, 5′GGTCTGTATCCAAC-
GCTCCT-3′; actb1 F, 5′TCAACACCCCTGCCATGTAT-3′ and R,
5′-CAGGAAGGAAGGCTGGAAGA-3′; gapdh F, 5′-TGTTCCAGTAC-
GACTCCACC-3′ and R, 5′-GCCATACCAGTAAGCTTGCC-3′] was
undertaken with DyNAmo HS SYBR green (F410L, Thermo Fisher
Scientific) on 175 ng/µl cDNA libraries, cycling (40 times) at 95°C for 25 s,
57.5°C for 30 s and 70°C for 45 s followed by a standard melt curve
(QuantStudio3, Applied Biosystems).
RNAseq
Triplicate samples of total RNA (three independent passages) fromWT and
giantin KO RPE-1 cells were analysed by RNAseq by the Earlham Institute
(formerly The Genome Analysis Centre). The methodology and analysis is
fully described elsewhere (Stevenson et al., 2017).
Quantification and statistical analysis
Statistical analyses were performed using GraphPad Prism 7.00. The tests
used and sample sizes are indicated in the figure legends, P-values are
shown on the figures. All tests met standard assumptions and the variation
between each group is shown. Sample sizes were chosen based on previous,
similar experimental outcomes and based on standard assumptions. No
samples were excluded. Randomisation and blinding were not used except
where the genotype of zebrafish was determined after experimentation.
Statistical significance was tested using one-way, non-parametric ANOVA
(Kruskal-Wallis test) with multiple comparisons using Dunn’s test.
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